Brickell Biotech, Inc. (BBI) reported Q2 EPS of ($0.01), $1.43 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.14 million.
Brickell Biotech, Inc. (BBI) reported Q2 EPS of ($0.01), $1.43 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.14 million.